Analysis of Macroglobulinemia, Waldenstrom, Susceptibility To, 1; WM1 method(s): ◦ Multicolor FISH (M-FISH) / Spectral Karotyping (tm) (SKY (tm)) ◦ Sequencing, Next Gen ◦ Sequencing, Capillary (Sanger) Center for Human Genetics and Laboratory Medicine Martinsried, Molecular Genetics - Martinsried, Germany |
MYD88 Gene Sequencing method(s): ◦ Sequencing, Capillary (Sanger) Cincinnati Children's Hospital Medical Center, Molecular Genetics Laboratory - Cincinnati, OH, USA |
Waldestrom Macroglobulinemia , Mutation (L265P) MYD88 Gene Whole Blood method(s): ◦ Mutation Scanning of Entire Coding Region Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
Waldestrom Macroglobulinemia , Mutation (L265P) MYD88 Gene Bone Marrow method(s): ◦ Mutation Scanning of Entire Coding Region Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
Inherited Disease Panel method(s): ◦ Sequencing, Next Gen Genomic Laboratory of the DNA Research Center LTD (Centrum Badań DNA sp z o.o.) - Poznań, Poland |
Waldenstrom macroglobulinemia (p.Leu265Pro mutation on MYD88 gene) method(s): ◦ Sequencing, Capillary (Sanger) CGC Genetics - Porto, Portugal |
MYD88 Deletion/duplication analysis method(s): ◦ Del/Dup (CNV) Cincinnati Children's Hospital Medical Center, Molecular Genetics Laboratory - Cincinnati, OH, USA |
Somatic Tumor Panel method(s): ◦ Sequencing, Next Gen CeGaT GmbH - Tübingen, Germany |
Defects in Innate Immunity Panel method(s): ◦ Sequencing, Next Gen CeGaT GmbH - Tübingen, Germany |
OnkoSight Myeloid Disorders Panel method(s): ◦ Sequencing, Next Gen GenPath - Elmwood Park, NJ, USA |
MYD88 method(s): ◦ Sequencing, Next Gen ◦ Sequencing, Capillary (Sanger) ◦ Del/Dup (CNV) Fulgent Diagnostics - Temple City, CA, USA |
Defects in intrinsic and innate immunity - predominant susceptibility to invasive infections with pyogenic bacteria (NGS panel of 2 genes) method(s): ◦ Sequencing, Next Gen CGC Genetics - Porto, Portugal |
Pyogenic bacterial infections, recurrent, due to MYD88 deficiency method(s): ◦ Sequencing, Capillary (Sanger) Centogene AG, Rare Disease Company - Rostock, Germany |
CEN4GEN Hematological malignancies (somatic genetic testing): Sequencing Panel method(s): ◦ Sequencing, Next Gen CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
TAT: 1-3 weeks price: $1,500.00
Invitae Mendelian Susceptibility to Mycobacterial Disease Panel method(s): ◦ Sequencing, Next Gen ◦ Del/Dup (CNV) Invitae - San Francisco, CA, USA |